Bryan A. Killinger

1.4k citations

25 papers · 943 indexed · h-index 20

Impact in

Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Biological Psychiatry top 10%
- Tryptophan and brain disorders

Papers in ⓘ

Neurology 14
- Parkinson's Disease Mechanisms and Treatments 14
Cellular and Molecular Neuroscience 7
- Neurotransmitter Receptor Influence on Behavior 4
- Genetic Neurodegenerative Diseases 3

Co-authors: Viviane Labrie (7 shared papers)Anna Moszczyńska (9 shared papers)Patrik Brundin (4 shared papers)Jeffrey H. Kordower (4 shared papers)Lena Brundin (2 shared papers)Honglei Chen (2 shared papers)Peipei Li (4 shared papers)Jacek Sikora (1 shared paper)
Journals: npj Parkinson s Disease (3 papers)Journal of Neurochemistry (3 papers)Acta Neuropathologica Communications (2 papers)Nature Communications (2 papers)Experimental Neurology (1 paper)
Partner nations: United States Lithuania Switzerland

In The Last Decade

Bryan A. Killinger

25 papers receiving 931 citations

Peers

Countries citing papers authored by Bryan A. Killinger

Since Specialization

Citations

This map shows the geographic impact of Bryan A. Killinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan A. Killinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan A. Killinger more than expected).

Fields of papers citing papers by Bryan A. Killinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan A. Killinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan A. Killinger. The network helps show where Bryan A. Killinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Bryan A. Killinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bryan A. Killinger Line = papers co-authored together Bryan A. Killinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The vermiform appendix impacts the risk of developing Parkinson’s disease Science Translational Medicine ·Bryan A. Killinger, Zachary Madaj, Jacek Sikora, Nolwen L. Rey, Alec J. Haas, Yamini Vepa, Daniel Lindqvist, Honglei Chen, Paul M. Thomas, Patrik Brundin, Lena Brundin, Viviane Labrie	2018	203
2	Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease Metabolites ·Peipei Li, Bryan A. Killinger, Elizabeth Ensink, Ian Beddows, Ali Yılmaz, Noah Lubben, Jared Lamp, Meghan Schilthuis, Irving E. Vega, Randy Woltjer, J. Andrew Pospisilik, Patrik Brundin, Lena Brundin, Stewart F. Graham, Viviane Labrie	2021	97
3	Epigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as neuroprotective Nature Neuroscience ·Lee Marshall, Bryan A. Killinger, Elizabeth Ensink, Peipei Li, Katie X. Li, Wei Cui, Noah Lubben, Matthew Weiland, Xinhe Wang, Juozas Gordevičius, Gerhard A. Coetzee, Jiyan Ma, Stefan Jovinge, Viviane Labrie	2020	64
4	Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room npj Parkinson s Disease ·Bryan A. Killinger, Ronald Melki, Patrik Brundin, Jeffrey H. Kordower	2019	61
5	Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures Journal of Colloid and Interface Science ·Duy Luong, Prashant Kesharwani, Bryan A. Killinger, Anna Moszczyńska, Fazlul H. Sarkar, Subhash Padhyé, Arun K. Rishi, Arun K. Iyer	2016	54
6	Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis Nature Communications ·Shraddha Pai, Peipei Li, Bryan A. Killinger, Lee Marshall, Peixin Jia, Ji Liao, Artūras Petronis, Piroska E. Szabó, Viviane Labrie	2019	49
7	Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats Psychopharmacology ·Lisa E. Baker, J Panos, Bryan A. Killinger, M. Melissa Peet, Lisa M. Bell, Larissa A. Haliw, Sheryl L. Walker	2009	41
8	Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine Molecules ·Yuran Xie, Bryan A. Killinger, Anna Moszczyńska, Olivia M. Merkel	2016	38
9	Spreading of alpha‐synuclein – relevant or epiphenomenon? Journal of Neurochemistry ·Bryan A. Killinger, Jeffrey H. Kordower	2019	35
10	Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity Experimental Neurology ·Bin Liu, Roberta Traini, Bryan A. Killinger, Bernard L. Schneider, Anna Moszczyńska	2013	33
11	Neurotoxic Methamphetamine Doses Increase LINE-1 Expression in the Neurogenic Zones of the Adult Rat Brain Scientific Reports ·Anna Moszczyńska, Amanda Flack, Ping Qiu, Alysson R. Muotri, Bryan A. Killinger	2015	29
12	In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain Proceedings of the National Academy of Sciences ·Bryan A. Killinger, Lee Marshall, Diptaman Chatterjee, Yaping Chu, José Brás, Rita Guerreiro, Jeffrey H. Kordower	2022	28
13	The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ? Journal of Parkinson s Disease ·Bryan A. Killinger, Viviane Labrie	2019	24
14	Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats Pharmacology Biochemistry and Behavior ·Bryan A. Killinger, M. Melissa Peet, Lisa E. Baker	2010	24
15	Screening Nylon-3 Polymers, a New Class of Cationic Amphiphiles, for siRNA Delivery Molecular Pharmaceutics ·Venkatareddy Nadithe, Runhui Liu, Bryan A. Killinger, Sara Movassaghian, (unknown), Anna Moszczyńska, Kristyn S. Masters, Samuel H. Gellman, Olivia M. Merkel	2014	23
16	Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease Nature Communications ·Juozas Gordevičius, Peipei Li, Lee Marshall, Bryan A. Killinger, Seán Lang, Elizabeth Ensink, Nathan C. Kuhn, Wei Cui, Nazia Maroof, Roberta Lauria, Christina Rueb, Juliane Siebourg‐Polster, Pierre Maliver, Jared Lamp, Irving E. Vega, Fredric P. Manfredsson, Markus Britschgi, Viviane Labrie	2021	22
17	Single and Binge Methamphetamine Administrations Have Different Effects on the Levels of Dopamine D2 Autoreceptor and Dopamine Transporter in Rat Striatum International Journal of Molecular Sciences ·Heli Chauhan, Bryan A. Killinger, Cheryl C. Miller, Anna Moszczyńska	2014	22
18	Vertebrate food products as a potential source of prion-like α-synuclein npj Parkinson s Disease ·Bryan A. Killinger, Viviane Labrie	2017	21
19	Co‐administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats Journal of Neurochemistry ·Bryan A. Killinger, Mrudang M. Shah, Anna Moszczyńska	2013	21
20	Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses Neurobiology of Disease ·Honglei Chen, Keran Wang, Filip Scheperjans, Bryan A. Killinger	2021	20

About Bryan A. Killinger

Bryan A. Killinger is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Virology and Sensory Systems, having authored 25 papers that have together received 943 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), RNA Interference and Gene Delivery (4 papers), Restless Legs Syndrome Research (3 papers), Receptor Mechanisms and Signaling (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Neurology (402 citations), Biological Psychiatry (62 citations), Neurology (123 citations), Cellular and Molecular Neuroscience (210 citations) and Physiology (206 citations). Bryan A. Killinger has collaborated with scholars based in United States, Lithuania and Switzerland. Frequent co-authors include Viviane Labrie, Anna Moszczyńska, Patrik Brundin, Jeffrey H. Kordower, Lena Brundin, Honglei Chen, Peipei Li, Jacek Sikora, Paul M. Thomas and Zachary Madaj. Their work appears in journals such as npj Parkinson s Disease, Journal of Neurochemistry, Acta Neuropathologica Communications, Nature Communications and Experimental Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact